Men who drink six cups of coffee a day showed a lower risk of developing a deadly type of prostate cancer compared with nondrinkers, a large U.S. study suggests. The study by researchers at the ...
The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca’s TRUQAP® (capivasertib) in combination with ...
This is what a frozen section of the prostate looks like. The researchers drilled small holes to extract tissue samples from areas where the gland contained cancer. It is precisely these tissue ...
An FDA advisory committee voted 7-1 to recommend expanding capivasertib use to treat PTEN-deficient metastatic hormone-sensitive prostate cancer, citing improved progression-free survival in a phase ...
EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX (R) platform, today announced the publication of a ...
Glowing prostate cancer cells PSMA PET 2. (PRIMARY 2 via SWNS) By Stephen Beech Scans that makes prostate cancer cells "glow" could cut the need for invasive biopsies, according to new research. The ...
MedPage Today on MSN
FDA Panel Endorses Broader Capivasertib Use in Prostate Cancer
Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful" ...
An FDA advisory committee has voted 7-1, with one abstention, to recommend approving AstraZeneca’s capivasertib in combination therapy for PTEN-deficient metastatic hormone-sensitive prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results